Homocysteinemia has been associated with oncogenic risk. This study was designed to investigate the homocysteine (Hcy) genotype/phenotype interactions together with the inflammatory and nutritional status of cancer patients.
Ferroni, P., Palmirotta, R., Martini, F., Riondino, S., Savonarola, A., Spila, A., et al. (2009). Determinants of homocysteine levels in colorectal and breast cancer patients. ANTICANCER RESEARCH, 29(10), 4131-4138.
Determinants of homocysteine levels in colorectal and breast cancer patients
Riondino, S;ROSELLI, MARIO;
2009-10-01
Abstract
Homocysteinemia has been associated with oncogenic risk. This study was designed to investigate the homocysteine (Hcy) genotype/phenotype interactions together with the inflammatory and nutritional status of cancer patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Determinants of homocysteine levels in colorectal and breast cancer patients.pdf
accesso aperto
Dimensione
190.25 kB
Formato
Adobe PDF
|
190.25 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
